Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias H Busch

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Clinical Journal of the American Society of Nephrology : CJASN|November 18, 2020
Urinary Soluble CD163 and Disease Activity in Biopsy-Proven ANCA-Associated GlomerulonephritisJoop P Aendekerk, Sjoerd A M E G Timmermans, Matthias H Busch, et al.
Journal of Clinical Medicine|December 23, 2022
Annexin A1 Is Associated with Adverse Clinical Outcomes in Patients with COVID-19Matthias H Busch, Sjoerd A M E G Timmermans, Joop P Aendekerk, et al.
Kidney International|April 23, 2023
Assessment of longitudinal serum neutrophil extracellular trap-inducing activity in anti-neutrophil cytoplasmic antibody-associated vasculitis and glomerulonephritis in a prospective cohort using a novel bio-impedance techniqueJoop P Aendekerk, Renée Ysermans, Matthias H Busch, et al.
Blood Advances|January 4, 2024
The intrinsic coagulation pathway plays a dominant role in driving hypercoagulability in ANCA-associated vasculitisMatthias H Busch, Renée Ysermans, Joop P Aendekerk, et al.
Clinical and Translational Science|January 14, 2022
The anti-C5a antibody vilobelimab efficiently inhibits C5a in patients with severe COVID-19Alexander P J Vlaar, Endry H T Lim, Sanne de Bruin, et al.
Haematologica|December 15, 2022
Thrombin formation via the intrinsic coagulation pathway and von Willebrand factor reflect disease severity in COVID-19Matthias H Busch, Sjoerd A M E G Timmermans, Sander M J Van Kuijk, et al.
Circulation|September 18, 2020
Neutrophils and Contact Activation of Coagulation as Potential Drivers of COVID-19Matthias H Busch, Sjoerd A M E G Timmermans, Magdolna Nagy, et al.
BMC Medicine|March 3, 2022
Risk factors associated with short-term adverse events after SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseasesLuuk Wieske, Laura Y L Kummer, Koos P J van Dam, et al.
Annals of the Rheumatic Diseases|January 31, 2023
Persistence of seroconversion at 6 months following primary immunisation in patients with immune-mediated inflammatory diseasesLuuk Wieske, Eileen W Stalman, P J Koos van Dam, et al.
Journal of Autoimmunity|January 9, 2023
Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinationsKoos P J van Dam, Luuk Wieske, Eileen W Stalman, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Clinical Journal of the American Society of Nephrology : CJASN|November 18, 2020
Urinary Soluble CD163 and Disease Activity in Biopsy-Proven ANCA-Associated GlomerulonephritisJoop P Aendekerk, Sjoerd A M E G Timmermans, Matthias H Busch, et al.
Journal of Clinical Medicine|December 23, 2022
Annexin A1 Is Associated with Adverse Clinical Outcomes in Patients with COVID-19Matthias H Busch, Sjoerd A M E G Timmermans, Joop P Aendekerk, et al.
Kidney International|April 23, 2023
Assessment of longitudinal serum neutrophil extracellular trap-inducing activity in anti-neutrophil cytoplasmic antibody-associated vasculitis and glomerulonephritis in a prospective cohort using a novel bio-impedance techniqueJoop P Aendekerk, Renée Ysermans, Matthias H Busch, et al.
Blood Advances|January 4, 2024
The intrinsic coagulation pathway plays a dominant role in driving hypercoagulability in ANCA-associated vasculitisMatthias H Busch, Renée Ysermans, Joop P Aendekerk, et al.
Clinical and Translational Science|January 14, 2022
The anti-C5a antibody vilobelimab efficiently inhibits C5a in patients with severe COVID-19Alexander P J Vlaar, Endry H T Lim, Sanne de Bruin, et al.
Haematologica|December 15, 2022
Thrombin formation via the intrinsic coagulation pathway and von Willebrand factor reflect disease severity in COVID-19Matthias H Busch, Sjoerd A M E G Timmermans, Sander M J Van Kuijk, et al.
Circulation|September 18, 2020
Neutrophils and Contact Activation of Coagulation as Potential Drivers of COVID-19Matthias H Busch, Sjoerd A M E G Timmermans, Magdolna Nagy, et al.
BMC Medicine|March 3, 2022
Risk factors associated with short-term adverse events after SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseasesLuuk Wieske, Laura Y L Kummer, Koos P J van Dam, et al.
Annals of the Rheumatic Diseases|January 31, 2023
Persistence of seroconversion at 6 months following primary immunisation in patients with immune-mediated inflammatory diseasesLuuk Wieske, Eileen W Stalman, P J Koos van Dam, et al.
Journal of Autoimmunity|January 9, 2023
Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinationsKoos P J van Dam, Luuk Wieske, Eileen W Stalman, et al.
Pageof 3